Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 3/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | CA12 | O43570 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | CA4 | P22748 | 2/20 | 0.55 |
| ▸ | CA6 | P23280 | 2/20 | 0.55 |
| ▸ | CA7 | P43166 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.53 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.53 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.53 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3388533 | 0.86 | KDM4E (0.57) | LCKKDM4ECA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL3914780 | 0.85 | KDM4E (0.52) | LCKKDM4ECA12CA1CA2 | |
| SCHEMBL9618790 | 0.85 | KDM4E (0.55) | LCKKDM4ECA12CA1CA2 | |
| SCHEMBL7088722 | 0.83 | PTPN1 (0.64) | KDM4ECA12CA1CA2MAPT | |
| SCHEMBL3914003 | 0.83 | KDM4E (0.53) | LCKKDM4ECA12CA1CA2 | |
| SCHEMBL3237472 | 0.83 | PTPN1 (0.61) | LCKKDM4ECA12CA1CA2 | |
| SCHEMBL2748359 | 0.81 | ESR1 (0.53) | LCKKDM4ECA12CA1CA2 | |
| SCHEMBL1434717 | 0.81 | ESR1 (0.53) | LCKKDM4ECA12CA1CA2 | |
| SCHEMBL4361721 | 0.81 | ESR1 (0.53) | LCKKDM4ECA12CA1CA2 | |
| SCHEMBL5485553 | 0.81 | KDM4E (0.52) | LCKKDM4ECA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114752043-B | Water-based alkyd resin composite material and preparation method and application thereof | 浙江传化涂料有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-114752043-A | Water-based alkyd resin composite material and preparation method and application thereof | 浙江传化涂料有限公司 | 2022-07-15 | — | — | CN | claimed |
| EP-3883916-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | Momentive Performance Materials GmbH (DE) | 2021-09-29 | — | — | EP | claimed |
| CN-113329993-A | Use of polyhydroxy aromatic compounds for treating fibrous substrates based on amino acids | 迈图高新材料有限责任公司 | 2021-08-31 | — | — | CN | claimed |
| US-20200163850-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2020-05-28 | — | — | US | claimed |
| US-11948662-B2 | Metabolite, annotation, and gene integration system and method | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-04-02 | — | — | US | disclosed |
| CN-114752043-B | Water-based alkyd resin composite material and preparation method and application thereof | 浙江传化涂料有限公司 | 2023-08-15 | — | — | CN | disclosed |
| US-20220296484-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2022-09-22 | — | — | US | disclosed |
| CN-114752043-A | Water-based alkyd resin composite material and preparation method and application thereof | 浙江传化涂料有限公司 | 2022-07-15 | — | — | CN | disclosed |
| EP-3230339-B1 | EPOXY RESIN COMPOSITION, PREPREG, FIBER-REINFORCED PLASTIC MATERIAL, AND MANUFACTURING METHOD FOR FIBER-REINFORCED PLASTIC MATERIAL | TORAY INDUSTRIES (JP) | 2022-03-23 | — | — | EP | disclosed |
| EP-3883916-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | Momentive Performance Materials GmbH (DE) | 2021-09-29 | — | — | EP | disclosed |
| CN-113329993-A | Use of polyhydroxy aromatic compounds for treating fibrous substrates based on amino acids | 迈图高新材料有限责任公司 | 2021-08-31 | — | — | CN | disclosed |
| CN-101802049-A | Epoxy resin composition for semiconductor encapsulation containing inclusion complex | NIPPON SODA CO | 2010-08-11 | — | — | CN | disclosed |
| US-20100179250-A1 | INCLUSION COMPLEX CONTAINING EPOXY RESIN COMPOSITION FOR SEMICONDUCTOR ENCAPSULATION | NIPPON SODA CO., LTD. (JP) | 2010-07-15 | — | — | US | disclosed |
| EP-2192139-A1 | INCLUSION COMPLEX CONTAINING EPOXY RESIN COMPOSITION FOR SEMICONDUCTOR ENCAPSULATION | Nippon Soda Co., Ltd. (JP) | 2010-06-02 | — | — | EP | disclosed |
| EP-0809493-B1 | A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS | US HEALTH (US) | 2002-09-11 | — | — | EP | disclosed |
| EP-0809493-A1 | A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-12-03 | — | — | EP | disclosed |
| US-5610185-A | Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-03-11 | — | — | US | disclosed |
| WO-1996025159-A1 | A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-08-22 | — | — | WO | disclosed |
| WO-1994003432-A1 | POLYHYDROXYLATED NAPHTHYL 2-CARBOXYLATE, AND QUINOLYL AND ISOQUINOLYL 3-CARBOXYLATE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS | THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220296484-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | PAH, CUTA, ASPH | LCK 1527/4885KDM4E 932/4885CA12 1878/4885 |
| US-20200163850-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | PAH, CUTA, ASPH | LCK 1527/4885KDM4E 932/4885CA12 1878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.